Bausch Health Cos Inc.

BHC-N

Analysis and Opinions about BHC-N

Signal
Opinion
Expert
COMMENT
COMMENT
December 24, 2019
Has been rangebound for two years, but recently broke out. That's good--it's going higher. Support around $36 and he predicts it will fall back here during the predicted market pullback to come.
Show full opinionHide full opinion
Has been rangebound for two years, but recently broke out. That's good--it's going higher. Support around $36 and he predicts it will fall back here during the predicted market pullback to come.
DON'T BUY
DON'T BUY
April 5, 2019
The former Valient Pharmaceuticals. It looks like it could rally $10 on a new breakout. Hold off until for a while as he does not see a real trend forming yet. Trade with a $28 stop-loss. (Analysts’ price target is $40.00)
Show full opinionHide full opinion
The former Valient Pharmaceuticals. It looks like it could rally $10 on a new breakout. Hold off until for a while as he does not see a real trend forming yet. Trade with a $28 stop-loss. (Analysts’ price target is $40.00)
HOLD
HOLD
December 28, 2018
There is no yield, so it falls outside his ranking system. Overall growth in earnings is basically flat. The PE ratio is only 5 times so he feels the market is somewhat skeptical.
Show full opinionHide full opinion
There is no yield, so it falls outside his ranking system. Overall growth in earnings is basically flat. The PE ratio is only 5 times so he feels the market is somewhat skeptical.
COMMENT
COMMENT
December 3, 2018
R&D-to-sales metric steered him away from Valeant (what Bausch used to be named). The current CEO is doing a great job transitioning and paying debt and de-risking the company. They appear to be doing well during this restructuring.
Show full opinionHide full opinion
R&D-to-sales metric steered him away from Valeant (what Bausch used to be named). The current CEO is doing a great job transitioning and paying debt and de-risking the company. They appear to be doing well during this restructuring.
DON'T BUY
DON'T BUY
September 17, 2018

You have been through ups and down with this one including a name change from Valiant. It has decent price momentum. They are trying to reconcile their balance sheet. Forward numbers look a lot better than backward looking numbers. They are not cheap enough and it is still a volatile stock. They have too much debt so avoid it.

Show full opinionHide full opinion

You have been through ups and down with this one including a name change from Valiant. It has decent price momentum. They are trying to reconcile their balance sheet. Forward numbers look a lot better than backward looking numbers. They are not cheap enough and it is still a volatile stock. They have too much debt so avoid it.

DON'T BUY
DON'T BUY
August 9, 2018

Formally Valiant. It had a rise and fall from grace. It bottomed over the last year. There is a lot of volatility. They addressed some of the concerns. Investors worry about R&D; and about drugs coming off patent. He does not know about their pipelines. If you can handle the risk, there are few companies where you can play the sector. There are more names in the US in this space that are attractive.

Show full opinionHide full opinion

Formally Valiant. It had a rise and fall from grace. It bottomed over the last year. There is a lot of volatility. They addressed some of the concerns. Investors worry about R&D; and about drugs coming off patent. He does not know about their pipelines. If you can handle the risk, there are few companies where you can play the sector. There are more names in the US in this space that are attractive.

Showing 1 to 6 of 6 entries
  • «
  • 1
  • »

Bausch Health Cos Inc.(BHC-N) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Bausch Health Cos Inc. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Bausch Health Cos Inc.(BHC-N) Frequently Asked Questions

What is Bausch Health Cos Inc. stock symbol?

Bausch Health Cos Inc. is a American stock, trading under the symbol BHC-N on the New York Stock Exchange (BHC). It is usually referred to as NYSE:BHC or BHC-N

Is Bausch Health Cos Inc. a buy or a sell?

In the last year, there was no coverage of Bausch Health Cos Inc. published on Stockchase.

Is Bausch Health Cos Inc. a good investment or a top pick?

Bausch Health Cos Inc. was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Bausch Health Cos Inc..

Why is Bausch Health Cos Inc. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Bausch Health Cos Inc. worth watching?

0 stock analysts on Stockchase covered Bausch Health Cos Inc. In the last year. It is a trending stock that is worth watching.

What is Bausch Health Cos Inc. stock price?

On 2020-07-02, Bausch Health Cos Inc. (BHC-N) stock closed at a price of $18.42.